Martina Damo

Martina Damo

Auto-generated profile, based on publicly available information

Martina Damo

Department of Medicine, University of Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2021 in Science Immunology
Verified
Journal Article
Open access
KCKelli A. Connolly
Kelli A. Connolly
MKManik Kuchroo
Manik Kuchroo
AVAarthi Venkat
Aarthi Venkat
AKAchia Khatun
Achia Khatun
JWJiawei Wang
Jiawei Wang
NJNikhil S. Joshi
Nikhil S. Joshi
Tumor-specific CD8 + T cells in stable tumor-draining lymph node reservoir are clonally and developmentally related to those in tumors.

14 February 2025 in Science
Verified
Journal Article
Closed access
EFEric Fagerberg
Eric Fagerberg
JAJohn Attanasio
John Attanasio
CDChristine Dien
Christine Dien
JSJaiveer Singh
Jaiveer Singh
EKEmily A. Kessler
Emily A. Kessler
NJNikhil S. Joshi
Nikhil S. Joshi
Naïve CD8 T cells have the potential to differentiate into a spectrum of functional states during an immune response. How these developmental decisions are made and what mechanisms exist to suppress differentiation toward alternative fates remains unclear. We employed in vivo CRISPR-Cas9–based perturbation sequencing to assess the role of ~40 transcription factors (TFs) and epigenetic modulators in T cell fate decisions. Unexpectedly, we found that knockout of the TF Klf2 resulted in aberrant differentiation to exhausted-like CD8 T cells during acute infection. KLF2 was required to suppress the exhaustion-promoting TF TOX and to enable the TF TBET to drive effector differentiation. KLF2 was also necessary to maintain a polyfunctional tumor-specific progenitor state. Thus, KLF2 provides effector CD8 T cell lineage fidelity and suppresses the exhaustion program.

31 October 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MKMoujtaba Y. Kasmani
Moujtaba Y. Kasmani
RZRyan Zander
Ryan Zander
HCH. Kay Chung
H. Kay Chung
YCYao Chen
Yao Chen
AKAchia Khatun
Achia Khatun
WCWeiguo Cui
Weiguo Cui
Although recent evidence demonstrates heterogeneity among CD8+ T cells during chronic infection, developmental relationships and mechanisms underlying their fate decisions remain incompletely understood. Using single-cell RNA and TCR sequencing, we traced the clonal expansion and differentiation of CD8+ T cells during chronic LCMV infection. We identified immense clonal and phenotypic diversity, including a subset termed intermediate cells. Trajectory analyses and infection models showed intermediate cells arise from progenitor cells before bifurcating into terminal effector and exhausted subsets. Genetic ablation experiments identified that type I IFN drives exhaustion through an IRF7-dependent mechanism, possibly through an IFN-stimulated subset bridging progenitor and exhausted cells. Conversely, Zeb2 was critical for generating effector cells. Intriguingly, some T cell clones exhibited lineage bias. Mechanistically, we identified that TCR avidity correlates with an exhausted fate, whereas SHP-1 selectively restricts low-avidity effector cell accumulation. Thus, our work elucidates novel mechanisms underlying CD8+ T cell fate determination during persistent infection and suggests two potential pathways leading to exhaustion.

21 June 2023 in Nature
Verified
Journal Article
Closed access
PDF file
MDMartina Damo
Martina Damo
NHNoah I. Hornick
Noah I. Hornick
AVAarthi Venkat
Aarthi Venkat
IWIvana William
Ivana William
KCKathryn Clulo
Kathryn Clulo
NJNikhil S. Joshi
Nikhil S. Joshi

27 July 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
MDMartina Damo
Martina Damo
BFBrittany Fitzgerald
Brittany Fitzgerald
YLYisi Lu
Yisi Lu
MNMursal Nader
Mursal Nader
IWIvana William
Ivana William
NJNikhil S. Joshi
Nikhil S. Joshi

22 March 2024 in Science Immunology
Verified
Journal Article
Closed access
MSMadison Strine
Madison Strine
EFEric Fagerberg
Eric Fagerberg
PDPatrick W. Darcy
Patrick W. Darcy
GBGabriel M. Barrón
Gabriel M. Barrón
RFRenata B. Filler
Renata B. Filler
CWCraig Wilen
Craig Wilen
The persistent murine norovirus strain MNV CR6 is a model for human norovirus and enteric viral persistence. MNV CR6 causes chronic infection by directly infecting intestinal tuft cells, rare chemosensory epithelial cells. Although MNV CR6 induces functional MNV-specific CD8 + T cells, these lymphocytes fail to clear infection. To examine how tuft cells promote immune escape, we interrogated tuft cell interactions with CD8 + T cells by adoptively transferring JEDI (just EGFP death inducing) CD8 + T cells into Gfi1b-GFP tuft cell reporter mice. Unexpectedly, some intestinal tuft cells partially resisted JEDI CD8 + T cell–mediated killing—unlike Lgr5 + intestinal stem cells and extraintestinal tuft cells—despite seemingly normal antigen presentation. When targeting intestinal tuft cells, JEDI CD8 + T cells predominantly adopted a T resident memory phenotype with decreased effector and cytotoxic capacity, enabling tuft cell survival. JEDI CD8 + T cells neither cleared nor prevented MNV CR6 infection in the colon, the site of viral persistence, despite targeting a virus-independent antigen. Ultimately, we show that intestinal tuft cells are relatively resistant to CD8 + T cells independent of norovirus infection, representing an immune-privileged niche that can be leveraged by enteric microbes.